Article info
PDFStandards
Original research
Neuroendovascular clinical trials disruptions due to COVID-19. Potential future challenges and opportunities
- Correspondence to Dr Ansaar T Rai, Department of Interventional Neuroradiology, West Virginia University Rockefeller Neuroscience Institute, Morgantown, West Virginia, USA; ansaar.rai{at}gmail.com
Citation
Neuroendovascular clinical trials disruptions due to COVID-19. Potential future challenges and opportunities
Publication history
- Received June 11, 2020
- Revised June 17, 2020
- Accepted June 20, 2020
- First published June 30, 2020.
Online issue publication
August 14, 2020
Article Versions
- Previous version (14 August 2020).
- Previous version (14 August 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.